Cargando…
Radiovirotherapy at twenty
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227365/ https://www.ncbi.nlm.nih.gov/pubmed/37260766 http://dx.doi.org/10.1016/j.omto.2023.05.003 |
| _version_ | 1785050755091136512 |
|---|---|
| author | Dingli, David |
| author_facet | Dingli, David |
| author_sort | Dingli, David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10227365 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | American Society of Gene & Cell Therapy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102273652023-05-31 Radiovirotherapy at twenty Dingli, David Mol Ther Oncolytics Commentary American Society of Gene & Cell Therapy 2023-05-26 /pmc/articles/PMC10227365/ /pubmed/37260766 http://dx.doi.org/10.1016/j.omto.2023.05.003 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Dingli, David Radiovirotherapy at twenty |
| title | Radiovirotherapy at twenty |
| title_full | Radiovirotherapy at twenty |
| title_fullStr | Radiovirotherapy at twenty |
| title_full_unstemmed | Radiovirotherapy at twenty |
| title_short | Radiovirotherapy at twenty |
| title_sort | radiovirotherapy at twenty |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227365/ https://www.ncbi.nlm.nih.gov/pubmed/37260766 http://dx.doi.org/10.1016/j.omto.2023.05.003 |
| work_keys_str_mv | AT dinglidavid radiovirotherapyattwenty |